Buy or sell: Ganesh Dongre of Anand Rathi recommends three shares to buy after stock market holiday
Ganesh Dongre of Anand Rathi recommends three stocks to buy or sell on Tuesday — Container Corporation of India (Concor), ...
Auto, Pharma Stocks Fall Up To 6% In 3 Sessions On US Tariff Fears; What Investors Should Know
In early trade on Friday, these stocks dropped by as much as 3%, with the Nifty Auto and Nifty Pharma indices trading lower ...
JD Supra2d
What’s the (Re)issue? Patent Term Extensions for Reissue Patents
Addressing the calculation of patent term extensions (PTEs) under the Hatch-Waxman Act, the US Court of Appeals for the Federal Circuit affirmed ...
U.S. tariff on automobiles turns spotlight on India pharma
U.S. President Trump imposes 25% tariff on auto imports, spotlight on pharma imports, Indian industry at risk.
Pharma stocks slip up to 3% as uncertainties loom around Trump tariffs
Shares of Aurobindo Pharmaceuticals dropped 2% to a day's low of Rs 1,132.75, while Ipca Laboratories fell 2.7% to Rs ...
Medical Dialogues3d
307 Cases of Drug Price Violations Surface, Big Pharma To Face Heat?
The issue of drug pricing violations has come under scrutiny, with the Parliamentary Standing Committee on Chemicals and ...
Taiwan News4d
India Generic Drugs Market is Predicted to Witness Healthy Growth During 2024 – 2032
The growth of the India generic drugs market is supported by proactive government policies aimed at bolstering the pharmaceutical sector. Initiatives such as the “Make in India” campaign and ...
JD Supra4d
Federal Circuit Clarifies Patent Term Extension Calculation for Reissue Patents
On March 13, 2025, the Federal Circuit issued a decision in Merck Sharp & Dohme B.V. v. Aurobindo Pharma USA, Inc., No. 23-2254 (Fed. Cir. 2025) ...
SCIENTURE Announces Commercial Operations Leadership and Strategic Agreement with Syneos Health, a leading Contract Sales Organization
“We are excited to collaborate with Scienture to enhance its commercial effectiveness,” said Paul Mignon, President, Deployment Solutions, Syneos Health. “Our team is committed to delivering tailored ...
Big Pharma faces heat as India records 307 drug pricing violations
Violations highlight growing concerns over the unchecked rise in medicine prices and their impact on affordability ...
What do Trump’s tariffs mean for Indian auto, pharma and steel stocks?
Experts underestimated Trump's seriousness on tariffs; Indian auto and pharma sectors brace for impact, while steel remains ...
Aurobindo Pharma update on preferential issue by Curateq Biologics
Curateq Biologics, a wholly owned subsidiary of Aurobindo Pharma, has allotted 4,125,055 Compulsory Convertible Preference Shares (CCPSs) of Rs.10/- each to Dr. Satakarni Makkapati on 20 March 2025.